Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum Sensitive Recurrent Ovarian Cancer
Abstract
Authors
L Zhong AT Tran T Tomasino JA Smith EK Nugent
L Zhong AT Tran T Tomasino JA Smith EK Nugent
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now